ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Seer Gets Concept Approval For Three More Years, With Several Changes

June 19, 1981

Michigan Scientist David Beer Sought Retraction Of Potti’s NEJM Paper Over Misuse Of His Data

July 30, 2010

Obituary: Carl Baker, Former NCI Director

March 13, 2009

The President’s Cancer Panel publishes its annual report

May 6, 2011

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976

Also in this 8-page issue: M.D. Anderson Cancer Center wins ninth SPORE grant, this time for melanoma research.

October 22, 2004